Susana Galli

1.2k citations
29 papers · 862 indexed · h-index 14
Topics
Neuroblastoma Research and Treatments (10 papers)Neuropeptides and Animal Physiology (6 papers)Cancer, Hypoxia, and Metabolism (5 papers)

In The Last Decade

Susana Galli

28 papers receiving 848 citations

Peers

Susana Galli
Comparison fields: 5 of 85
  • Molecular Biology 357
  • Oncology 331
  • Immunology 226
  • Cancer Research 115
  • Neurology 108
Replace Daniela Murtas with:
Daniela Murtas Italy
Tarja Lamminen Finland
Heribert Appelhans Germany
Jinmin Miao United States
Yazhong Tao United States
Lin Q China
T Campbell United Kingdom
M. Isabel Chiu United States
Shih‐Yin Tsai United States
Corinne Bareil France
Susana Galli relative to Daniela Murtas Italy Daniela Murtas's profile →
Citations per field
00.5×3.4×
Daniela Murtas · 1×
Citations per year

Countries citing papers authored by Susana Galli

Since Specialization
Citations

This map shows the geographic impact of Susana Galli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susana Galli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susana Galli more than expected).

Fields of papers citing papers by Susana Galli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susana Galli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susana Galli. The network helps show where Susana Galli may publish in the future.

Co-authorship network of co-authors of Susana Galli

This figure shows the co-authorship network connecting the top 25 collaborators of Susana Galli. A scholar is included among the top collaborators of Susana Galli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susana Galli. Susana Galli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 5
3 11
4 8
5 52
6 1
7 258
8 5
9 19
10 23
11 29
12 6
13 29
14 63
15 47
16 17
17 3
18 4
19 4
20
[Contribution to the study of Gricouroff's metastatic thyroidosis].
1

About Susana Galli

Susana Galli is a scholar working on Neurology, Cancer Research and Cellular and Molecular Neuroscience, having authored 29 papers that have together received 862 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (10 papers), Neuropeptides and Animal Physiology (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Oncology (331 citations), Immunology (226 citations) and Ophthalmology (91 citations). Susana Galli has collaborated with scholars based in United States, Poland and Argentina. Frequent co-authors include Maria Tsokos, Sneha Ramakrishna, Alec J. Walker, Steven L. Highfill, Rimas J. Orentas, Crystal L. Mackall, Jillian Smith, Adrienne H. Long, Yongzhi Cui and David D. Roberts. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026